Page last updated: 2024-08-25

tocophersolan and simvastatin

tocophersolan has been researched along with simvastatin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
He, J; Liu, J; Zhang, M; Zhang, W	1
Attia, Y; El-Nabarawi, M; Mahmoud, K; Swidan, S; Teaima, M	1

Other Studies

2 other study(ies) available for tocophersolan and simvastatin

Article	Year
Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation. Pharmaceutical research, 2018, Aug-30, Volume: 35, Issue:11 Topics: Animals; Atherosclerosis; Drug Carriers; Drug Liberation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liposomes; Mice; Nanoparticles; Oxidative Stress; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; RAW 264.7 Cells; Simvastatin; Surface Properties; Vitamin E	2018
Size-optimized simvastatin-loaded TPGS modified lipid nanocapsules for targeting epithelial-to-mesenchymal transition in hepatocellular carcinoma: Role of PTEN/AKT signaling. Expert opinion on drug delivery, 2023, Volume: 20, Issue:5 Topics: alpha-Tocopherol; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Lipids; Liver Neoplasms; Nanocapsules; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Simvastatin; Tissue Distribution	2023

Article

Year

Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation.

Pharmaceutical research, 2018, Aug-30, Volume: 35, Issue:11

Topics: Animals; Atherosclerosis; Drug Carriers; Drug Liberation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liposomes; Mice; Nanoparticles; Oxidative Stress; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; RAW 264.7 Cells; Simvastatin; Surface Properties; Vitamin E

2018

Size-optimized simvastatin-loaded TPGS modified lipid nanocapsules for targeting epithelial-to-mesenchymal transition in hepatocellular carcinoma: Role of PTEN/AKT signaling.

Expert opinion on drug delivery, 2023, Volume: 20, Issue:5

Topics: alpha-Tocopherol; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Lipids; Liver Neoplasms; Nanocapsules; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Simvastatin; Tissue Distribution

2023